Takeda Begins Sales Of Hyperlipidemia Drug Lotriga
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals launched Rotoriga (omega-3 fatty acid) for the treatment of hyperlipidemia, the company announced Jan. 10.